Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded spectrum cephalosporins and aztreonam?

Journal of Clinical Microbiology

Volumn 36, Issue 9, 1998, Pages 2575-2579

  Moland, Ellen Smith ^a   Sanders, Christine C ^a   Thomson, Kenneth S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFPODOXIME; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; DIAGNOSTIC TEST; DILUTION; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 0031826529     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.9.2575-2579.1998     Document Type: Article

References (35)

1. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.
2. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761-766.
3. Bush, K. 1996. Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur. J. Clin. Microbiol. Infect. Dis. 15:361-364.
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
5. Casellas, J. M., and M. Goldberg. 1989. Incidence of strains producing extended spectrum β-lactamases in Argentina. Infection 17:434-436.
6. Chanal, C., D. Sirot, J. P. Romaszko, L. Bret, and J. Sirot. 1996. Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. J. Antimicrob. Chemother. 38:127-132.
7. Cormican, M. G., S. A. Marshall, and R. N. Jones. 1996. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen. J. Clin. Microbiol. 34:1880-1884.
8. Goldstein, F. W., Y. Péan, A. Rosato, J. Gertner, L. Gutmann, and the Vigil'Roc Study Group. 1993. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. J. Antimicrob. Chemother. 32:595-603.
9. Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.
10. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J. Clin. Microbiol. 32:691-696.
11. Livermore, D. M. 1995. β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
12. Matthew, M. A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
13. Medeiros, A. A. 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24(Suppl. 1): S19-S45.
14. Meyer, K. S., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Rahal. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann. Intern. Med. 119:353-358.
15. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Naumovski, L., J. P. Quinn, D. Miyashiro, M. Patel, K. Bush, S. B. Singer, D. Graves, T. Palzkill, and A. M. Arvin. 1992. Outbreak of ceftazidime resistance due to extended-spectrum β-lactamases in isolates from cancer patients. Antimicrob. Agents Chemother. 36:1991-1996.
18. Nüesch-Inderbinen, M. T., H. Hächler, and F. H. Kayser. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402.
19. O'Callaghan, C. H., P. W. Muggleton, and G. W. Ross. 1969. Effects of β-lactamase from gram-negative organisms on cephalosporins and penicillins, p. 57-63. Antimicrob. Agents Chemother. 1968.
20. Pangon, B., C. Bizet, F. Pichon, A. Philippon, B. Regnier, A. Bure, and L. Gutmann. 1989. In vivo selection of a cephamycin resistant porin mutant of a CTX-1 β-lactamase producing strain of Klebsiella pneumoniae. J. Infect. Dis. 159:1005-1006.
21. Philippon, A., S. B. Redjeb, G. Fournier, and A. B. Hassen. 1989. Epidemiology of extended spectrum β-lactamases. Infection 17:347-354.
22. Pitout, J. D. D., E. S. Moland, and C. C. Sanders. 1996. Changes in porin expression associated with the stepwise increase in resistance to cefoxitin in Klebsiella pneumoniae involved in nosocomial infections, abstr. C39, p. 41. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Rice, L. B., S. H. Marshall, L. L. Carias, L. Sutton, and G. A. Jacoby. 1993. Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum β-lactamase genes. Antimicrob. Agents Chemother. 37:2760-2761.
24. Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, Robert C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193-2199.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. Sanders, C. C. 1992. β-lactamases of gram-negative bacteria: new challenges for new drugs. Clin. Infect. Dis. 14:1089-1099.
27. Sanders, C. C., A. L. Barry, J. A. Washington, C. Shubert, E. S. Moland, M. M. Traczewski, C. Knapp, and R. Mulder. 1996. Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. J. Clin. Microbiol. 34:2997-3001.
28. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
29. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
30. Sirot, D. L., F. W. Goldstein, C. J. Soussy, A. L. Courtieu, M. O. Husson, J. Lemozy, M. Meyran, C. Morel, R. Perez, C. Quentin-Noury, M. E. Reverdy, J. M. Scheftel, M. Rosembaum, and Y. Rezvani. 1992. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob. Agents Chemother. 36:1677-1681.
31. Thomson, K. S., E. S. Moland, and C. C. Sanders. 1998. Use of Microdilution panels with and without β-lactamase inhibitors as a specific test for β-lactamase production among E. coli and Klebsiella. Submitted for publication.
32. Thomson, K. S., A. M. Prevan, and C. C. Sanders. 1996. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics, p. 151-163. In J. S. Remington and M. N. Swartz (ed.), Current clinical topics in infectious diseases, vol. 16. Blackwell Science, Inc., Cambridge, Mass.
33. Thomson, K. S., and C. C. Sanders. 1997. A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM-and SHV-derived extended-spectrum β-lactamases. Clin. Microbiol. Infect. 3:549-554.
34. Vatopoulos, A. C., A. Philippon, L. S. Tzouvelekis, Z. Komninou, and N. J. Legakis. 1990. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J. Antimicrob. Chemother. 26:635-648.
35. Vercauteren, E., P. Descheemaeker, M. Ieven, C. C. Sanders, and H. Goossens. 1997. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Microbiol. 35:2191-2197.